Abstract
A patient who had carcinoid tumor of the ileum and liver and intraabdominal lymph-node metastases sustained a substantial (more than 50%) reduction of metastatic tumor burden when treated with accelerated-dosage octreotide.
MeSH terms
-
Antineoplastic Agents, Hormonal / administration & dosage*
-
Carcinoid Tumor / drug therapy*
-
Carcinoid Tumor / secondary
-
Dose-Response Relationship, Drug
-
Humans
-
Ileal Neoplasms / drug therapy
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary
-
Lymphatic Metastasis
-
Male
-
Octreotide / administration & dosage*
-
Remission Induction
-
Tomography, X-Ray Computed
Substances
-
Antineoplastic Agents, Hormonal
-
Octreotide